Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Colgate-Palmolive Company (CL) has a Wall Street consensus price target of $92.45, based on estimates from 43 covering analysts. With the stock currently trading at $99.14, this represents a potential downside of -6.7%. The company has a market capitalization of $79.91B.
Analyst price targets range from a low of $85.00 to a high of $100.00, representing a 16% spread in expectations. The median target of $93.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 16 analysts rating the stock as a Buy or Strong Buy,25 rating it Hold, and 2 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, CL trades at a trailing P/E of 37.7x and forward P/E of 25.7x. Analysts expect EPS to grow +45.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $126.72, with bear and bull scenarios of $94.45 and $166.80 respectively. Model confidence stands at 75/100, indicating high predictability in the company's fundamentals.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CL stacks up against sector leader Walmart Inc..
Start ComparisonWall Street's consensus price target for CL is $92.45, -6.7% from its current price of $99.14. The below-market target from 43 analysts suggests limited near-term appreciation.
CL has a consensus rating of "Hold" based on 43 Wall Street analysts. The rating breakdown is mixed, with 25 Hold ratings making up the largest segment. The consensus 12-month price target of $92.45 implies -6.7% downside from current levels.
CL trades at a forward P/E of 25.656x, representing a moderate valuation. With analysts targeting $92.45 (-6.7% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $100 for CL, while the most conservative target is $85. The consensus of $92.45 represents the median expectation. Our quantitative valuation model projects a bull case target of $167 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CL is heavily covered by Wall Street, with 43 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 16 have Buy ratings, 25 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CL stock forecast based on 43 Wall Street analysts shows a consensus price target of $92.45, with estimates ranging from $85 (bear case) to $100 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $127, with bear/bull scenarios of $94/$167.
Our quantitative valuation model calculates CL's fair value at $127 (base case), with a bear case of $94 and bull case of $167. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 75/100.
CL trades at a forward P/E ratio of 25.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 37.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on CL, with 2 Sell ratings and a price target of $92.45 (-6.7% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CL analyst price targets range from $85 to $100, a 16% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $92.45 consensus represents the middle ground. Our model's $94-$167 range provides an independent fundamental perspective.